Cue Biopharma
CUE
CUE
46 hedge funds and large institutions have $11.8M invested in Cue Biopharma in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 10 closing their positions.
Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Group One Trading
Chicago,
Illinois
| – | – | -13,572 | Closed |
|
|
TSS
52
Two Sigma Securities
New York
| – | – | -10,390 | Closed |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| – | – | -3,874 | Closed |
|
54
Simplex Trading
Chicago,
Illinois
| – | – | -2,395 | Closed |
|
|
MG
55
Mather Group
Chicago,
Illinois
| – | – | -1,000 | Closed |
|
|
SFG
56
Stonebridge Financial Group
Wormleysburg,
Pennsylvania
| – | – | -62 | Closed |
|
57
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|